Latest Galena Biopharma Stories
Cancer Immunotherapy Month Focuses on Raising Awareness for the Most Promising Form of Cancer Treatment Today New York (PRWEB) May 20, 2015 Cancer immunotherapy,
Median progression-free survival of 7.6 months reported for overall study population whose disease has progressed on a median of 4 prior therapies CAMBRIDGE, Mass., April 20, 2015 /PRNewswire/
RnRMarketResearch.com adds HER-2 Positive Breast Cancer Market in the US 2015-2019 and Global HER-2 Positive Breast Cancer Market 2015-2019 industry research reports in its store. DALLAS, March
LONDON, March 17, 2015 /PRNewswire/ -- Executive Summary--The global breast cancer therapeutics market is divided into x segments: hormonal therapy, targeted therapy, chemotherapy,
The use of combination targeted therapies will improve progression-free disease as well as survival rates, finds Frost & Sullivan LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability
WORCESTER, Mass. and TORONTO, Feb.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.